Evidence map›Paper›PMID 36847515›Full record

ReviewClinical microbiology reviews2023

Agnostic Sequencing for Detection of Viral Pathogens.

Nick P G Gauthier, Samuel D Chorlton, Mel Krajden, Amee R Manges

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Metagenomic next-generation sequencing: new horizons in microbiology.Frontiers in cellular and infection microbiology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. iScience · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Shotgun metagenomics on indoor air for surveillance of respiratory, enteric, and skin viruses in a Belgian daycare setting, January to December 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nick P G GauthierDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-9484-6223
Samuel D ChorltonBugSeq Bioinformatics Inc., Vancouver, British Columbia, Canada.
Mel KrajdenDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Amee R MangesBritish Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.ORCID 0000-0003-2462-7249

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of next-generation sequencing (NGS) technologies has expanded our ability to detect and analyze microbial genomes and has yielded novel molecular approaches for infectious disease diagnostics. While several targeted multiplex PCR and NGS-based assays have been widely used in public health settings in recent years, these targeted approaches are limited in that they still rely on

Indexed as

VirusesBacteriaGenome, ViralHigh-Throughput Nucleotide SequencingMetagenomicsdiagnosticmetagenomicmolecular epidemiologynext-generation sequencingrespiratory virusesSARS-CoV-2viral diagnostics

Identifiers

PMID36847515
PMCPMC10035330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.